| MSAA | multiple sclerosis-associated agent |
|---|---|
| MSS | Marshall-Smith syndrome; massage; Medical Superintendents' Society; Medicare Statistical System; men... |
| MSSG | multiple sclerosis susceptibility gene |
| NMSS | National Multiple Sclerosis Society |
| SRS | schizophrenic residual state; sex reassignment surgery; Silver-Russell syndrome; simple repeat seque... |
| unicellular sclerosis | A growth of fibrous tissue between and isolating the individual cells of a part. (05 Mar 2000) |
|---|---|
| focal sclerosis | <neurology> Neurodegenerative disease characterised by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in 3rd or 4th decade with intermittent progression over an extended period. Cause still uncertain. (18 Nov 1997) |
| focal sclerosis with hyalinosis | <nephrology> A kidney disorder that results in fibrosis and scarring in the kidney glomerulus. The cause is unknown but some cases can result from reflux nephropathy. The clinical manifestation of this kidney disorder is nephrotic syndrome. Symptoms include weight gain, swelling, hypertension and foamy urine. High blood cholesterol and triglyceride levels are also seen with this disorder. Treatment has included the use of corticosteroids and immunosuppressives. Antihypertensive agents and diuretics may also be necessary. Over one-half will develop chronic renal failure within 10 years of diagnosis. (27 Sep 1997) |
| laminar cortical sclerosis | A degeneration of nerve fibres in the corona radiata in a laminar pattern. (05 Mar 2000) |
| lateral spinal sclerosis | Considered by many to be a subgroup of motor neuron disease; a slowly progressive degenerative disorder of the motor neurons of the cerebral cortex, resulting in widespread weakness on an upper motor neuron basis; spasticity, hyperreflexia, and Babinski signs are present, but not fasciculation potentials, nor any electrodiagnostic evidence of a lower motor neuron lesion. Synonym: lateral spinal sclerosis. (05 Mar 2000) |
| lobar sclerosis | Circumscribed atrophy of the cerebral cortex. Synonym: lobar sclerosis, progressive circumscribed cerebral atrophy. (05 Mar 2000) |
| abbreviated injury scale | Classification system for assessing impact injury severity developed and published by the american association for automotive medicine. It is the system of choice for coding single injuries and is the foundation for methods assessing multiple injuries or for assessing cumulative effects of more than one injury. These include maximum ais (mais), injury severity score (iss), and probability of death score (pods). (12 Dec 1998) |
| absolute scale | An obsolete term for Kelvin scale. (05 Mar 2000) |
| activities of daily living scale | A scale to score physical activity and its limitations, based on answers to simple questions about mobility, self-care, grooming, etc; widely used in geriatrics, rheumatology, etc. (05 Mar 2000) |
| Angstrom scale | A table of wavelengths of a large number of light rays corresponding to as many Fraunhofer's lines in the spectrum. (05 Mar 2000) |
| Baume scale | A hydrometer scale for determining the specific gravity of liquids heavier and lighter than water, respectively: for liquids lighter than water, divide 140 by 130 plus the Baume degree; for liquids heavier than water, divide 145 by 145 minus the Baume degree. (05 Mar 2000) |
| Binet scale | A measure of intelligence designed for both children and adults. (05 Mar 2000) |
| Binet-Simon scale | Forerunner of individual intelligence tests, particularly the Stanford-Binet intelligence scale, and sometimes referred to as the Binet scale. (05 Mar 2000) |
| Brazelton's Neonatal Behavioural Assessment Scale | A scale used by obstetricians, paediatricians, and paediatric psychologists to assess the sensory, motor, emotional and physical development of the neonate, usually beginning at birth or in the first month of life. (05 Mar 2000) |
| brief psychiatric rating scale | A scale comprising 18 symptom constructs chosen to represent relatively independent dimensions of manifest psychopathology. The initial intended use was to provide more efficient assessment of treatment response in clinical psychopharmacology research; however, the scale was readily adapted to other uses. (12 Dec 1998) |